Pfizer (NYSE:PFE) Holds 7% Yield as AI Selloff Hits, Options Traders Look for Protection
New York, July 13, 2026, 17:11 (EDT) Pfizer (NYSE:PFE) added 1.28% to $24.48 in post-market trading Monday. The stock outperformed the broader market and two other major pharma names while investors…
Read the full articleYou might also wanna read
Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
The pharma giant's yield of around 7.1% is more than six times the S&P 500 average.
Opinion: Pfizer's Dividend Is Riskier Than You Might Think
A 7% dividend yield will grab your attention, but be sure to read the fine print.
Abivax: Wall Street Catches Up to the Data
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underw
‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend
Jim Cramer stared down a stock yielding 7% and sitting near its 52-week low, and still would not tell viewers to buy it. On the July 7 episo
Chip stocks boost global markets ahead of SK Hynix blockbuster US debut
European shares were muted on Friday, with the pan-European STOXX 600 up 0.1%, remaining on track for a weekly loss that could snap a four-
Polymarket odds lift July Fed hold to 78% as hike risk stays on ladder
U.S. stocks inched higher as AI-linked winners extended weekly gains, with Treasury yields also ticking up ahead of major bank earnings. (Re
Comments
Sign in to join the conversation.
No comments yet. Be the first.